The clinical treatment outcomes and side effects of tigecycline in infectious diseases
碩士 === 國立臺灣大學 === 臨床藥學研究所 === 100 === Background: Tigecycline is approved by the USA Food and Drug Administration（FDA） for the treatment of complicated intra-abdominal infections（cIAIs）, complicated skin and skin structure infections（cSSSIs）, and community acquired pneumonia（CAP）. Tigecycline is act...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2012
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/764zdf |